South Dakota Investment Council’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-2,400
Closed -$109K 615
2020
Q4
$109K Hold
2,400
﹤0.01% 593
2020
Q3
$85K Hold
2,400
﹤0.01% 589
2020
Q2
$91K Sell
2,400
-26,416
-92% -$870K ﹤0.01% 573
2020
Q1
$833K Sell
28,816
-55
-0.2% -$2.23K 0.02% 389
2019
Q4
$1.5M Sell
28,871
-26,849
-48% -$1.56M 0.03% 360
2019
Q3
$3.06M Sell
55,720
-5,780
-9% -$297K 0.06% 277
2019
Q2
$2.5M Sell
61,500
-18,321
-23% -$668K 0.05% 270
2019
Q1
$2.41M Buy
79,821
+5,400
+7% +$185K 0.05% 278
2018
Q4
$2.5M Hold
74,421
0.06% 241
2018
Q3
$3.14M Buy
74,421
+21,221
+40% +$839K 0.07% 229
2018
Q2
$1.7M Buy
53,200
+8,569
+19% +$353K 0.04% 346
2018
Q1
$2.22M Hold
44,631
0.05% 285
2017
Q4
$2.41M Sell
44,631
-8,400
-16% -$465K 0.05% 274
2017
Q3
$3.08M Hold
53,031
0.06% 229
2017
Q2
$2.62M Hold
53,031
0.06% 263
2017
Q1
$2.3M Buy
53,031
+6,831
+15% +$326K 0.05% 295
2016
Q4
$2.26M Hold
46,200
0.05% 288
2016
Q3
$2.21M Buy
46,200
+7,500
+19% +$370K 0.05% 288
2016
Q2
$2.08M Buy
+38,700
New +$1.82M 0.05% 279

Other funds holding ANIK

South Dakota Investment Council's ANIK Position: Q1 2021 in Review

South Dakota Investment Council sold out of Anika Therapeutics (ANIK) in Q1 2021, closing a stake of 2,400 shares — an estimated $109K sold.

South Dakota Investment Council first reported a position in ANIK in Q2 2016 and held it in 19 quarters. The position peaked at $3.14M in Q3 2018. 146 funds tracked by Wall St. Rank hold ANIK as of Q1 2021.

  • South Dakota Investment Council reported no remaining Anika Therapeutics position as of Q1 2021 after selling out during the quarter.
  • South Dakota Investment Council sold 2,400 Anika Therapeutics shares in Q1 2021, an estimated $109K.
  • South Dakota Investment Council first reported a position in Anika Therapeutics in Q2 2016 and held it in 19 quarters.
  • South Dakota Investment Council's Anika Therapeutics position peaked at $3.14M in Q3 2018.
  • 146 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2021.

Based on South Dakota Investment Council's 13F filing for Q1 2021, filed 13 May 2021.